Head of Early Development Biopharmacy
Sanofi
Cambridge, Massachusetts
Fady is leading the groups of Biopharmaceutics and formulation in Sanofi USA to develop a strategy for DP development for successful transition to clinical phases and subsequent market launch. His expertise has been honed through his education and career. He obtained his PhD from the University of Houston and completed post-doctoral training at the University of British Columbia, Vancouver Canada. He joined the Biopharm group at Pfizer and then moved to Sanofi to lead the Early Development Biopharmcy group. Fady is passionate about advancing the molecules into clinics and developing innovative strategies for drug product development.
Disclosure information not submitted.
Beyond Compendial in-vivo Predictive Tools in Early Drug Product Development
Tuesday, October 22, 2024
9:30 AM – 10:00 AM MT